Results 51 to 60 of about 19,293 (297)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer

Креативная хирургия и онкология, 2022
Background. Ovarian cancer ranks 5th in the structure of female oncological mortality in the Russian Federation, with a first-year post-diagnosis rate of almost 35%. In 75% cases, ovarian cancer is diagnosed at stages III—IV.
M. V. Zabelin, A. S. Safonov, N. V. Kuznetsov   +2 more
doaj   +1 more source

Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis [PDF]

, 2015
Background Peritoneal carcinomatosis occurs in different cancer subtypes and is associated with a dismal prognosis. Some doubts remain whether the whole abdomen can be treated by regional hyperthermia, therefore we analyzed feasibility conducting a pilot
Beck, Marcus, Budach, Volker, Burock, Susen, Ghadjar, Pirus, Nadobny, Jacek, Sehouli, Jalid, Weihrauch, Mirko, Wust, Peter   +7 more
core   +2 more sources

Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients

British Journal of Cancer, 2021
Patients with metastatic colorectal cancer (mCRC) carrying BRAF (mutBRAF) or KRAS mutation (mutKRAS) have an inferior prognosis after liver or lung surgery, whereas the prognostic role in the context of peritoneal metastasis (PM) after cytoreductive ...
S. Larsen, M. Goscinski, S. Dueland, S. Steigen, E. Hofsli, A. Torgunrud, M. Lund-Iversen, V. Dagenborg, K. Flatmark, H. Sørbye   +9 more
semanticscholar   +1 more source

Intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis: is HIPEC the only answer? [PDF]

, 2014
Gastric cancer with peritoneal carcinomatosis is notorious for its dismal prognosis. While the pathophysiology of peritoneal dissemination is still controversial, the rapid downhill course is universal.
Kwong, DLW, Lam, KO, Law, BTT, Law, SYK
core   +1 more source

Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review

World Journal of Surgical Oncology
Colorectal peritoneal metastases (CRPM) are present in 10–20% of patients at the time of their initial cancer diagnosis, and affects over 20% of those who develop colorectal cancer recurrence.
M. Sarofim, R. Wijayawardana, Nima Ahmadi, D. Morris   +3 more
semanticscholar   +1 more source

Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study

World Journal of Surgical Oncology, 2020
Background Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC. Methods
Paul Dranichnikov, Wilhelm Graf, Peter H. Cashin   +2 more
doaj   +1 more source

Efficacy of Cytoreductive Surgery (CRS) + HIPEC in Gastric Cancer with Peritoneal Metastasis: Systematic Review and Meta-Analysis

Cancers
Simple Summary Peritoneal disease in gastric cancer has a poor prognosis, with a median survival of 3–6 months and a 5-year survival rate of 0%. Despite multiple advancements in therapeutics, the National Comprehensive Cancer Network (NCCN) guidelines ...
L. Langellotti, C. Fiorillo, G. D’Annibale, Edoardo Panza, Fabio Pacelli, S. Alfieri, A. di Giorgio, F. Santullo   +7 more
semanticscholar   +1 more source

HIPEC-Induced Acute Kidney Injury: A Retrospective Clinical Study and Preclinical Model

Annals of Surgical Oncology, 2021
Background Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery (CRS) is the treatment of choice for selected patients with peritoneal malignancies.
Lukas F. Liesenfeld, B. Wagner, H. Hillebrecht, M. Brune, C. Eckert, J. Klose, T. Schmidt, M. Büchler, Martin Schneider   +8 more
semanticscholar   +1 more source

Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC

World Journal of Surgical Oncology, 2023
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of selected patients with peritoneal metastasis. A major cause of treatment-related morbidity after CRS/HIPEC is infection and sepsis. HIPEC
Lilian Roth, Dilmurodjon Eshmuminov, Linda Russo, Felix Laminger, Friedrich Kober, Sebastian Roka, Kuno Lehmann   +6 more
doaj   +1 more source

Investigation of the Possible Functions of PACAP in Human Trophoblast Cells [PDF]

, 2014
Pituitary adenylate cyclase activating polypeptide (PACAP) is an endogenous neuropeptide having a widespread distribution both in the nervous system and peripheral organs including the female reproductive system.
Barakonyi, A., Brubel, R., Cohen, M., Fabian, E., Halasz, M., Horvath, G., Opper, B., Reglődi, D., Szereday, L., Tamas, A., Tóth, G.   +10 more
core   +1 more source